200 related articles for article (PubMed ID: 10049714)
21. Effects of cerebral ischemia on dopamine receptors in the gerbil striatum.
Araki T; Kato H; Shuto K; Fujiwara T; Kogure K; Itoyama Y
Eur J Pharmacol; 1996 Jun; 306(1-3):73-9. PubMed ID: 8813617
[TBL] [Abstract][Full Text] [Related]
22. Differentiation of 5-hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin.
McKenna DJ; Peroutka SJ
J Neurosci; 1989 Oct; 9(10):3482-90. PubMed ID: 2795135
[TBL] [Abstract][Full Text] [Related]
23. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
[TBL] [Abstract][Full Text] [Related]
24. Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites.
Malmberg A; Jerning E; Mohell N
Eur J Pharmacol; 1996 May; 303(1-2):123-8. PubMed ID: 8804920
[TBL] [Abstract][Full Text] [Related]
25. (-)S amisulpride binds with high affinity to cloned dopamine D(3) and D(2) receptors.
Castelli MP; Mocci I; Sanna AM; Gessa GL; Pani L
Eur J Pharmacol; 2001 Dec; 432(2-3):143-7. PubMed ID: 11740949
[TBL] [Abstract][Full Text] [Related]
26. Dopamine D2-like receptors on human peripheral blood lymphocytes: a radioligand binding assay and immunocytochemical study.
Amenta F; Bronzetti E; Felici L; Ricci A; Tayebati SK
J Auton Pharmacol; 1999 Jun; 19(3):151-9. PubMed ID: 10511471
[TBL] [Abstract][Full Text] [Related]
27. In vivo occupancy of dopamine D2 receptors by antipsychotic drugs and novel compounds in the mouse striatum and olfactory tubercles.
Assié MB; Dominguez H; Consul-Denjean N; Newman-Tancredi A
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):441-50. PubMed ID: 16947046
[TBL] [Abstract][Full Text] [Related]
28. Characterization of [3H]nemonapride binding to mouse brain dopamine D2 receptors assessed in vivo and ex vivo for metabolic modeling in PET studies.
Ishiwata K; Inami K; Sasaki T; Nozaki T; Senda M
J Neural Transm Gen Sect; 1994; 97(2):119-33. PubMed ID: 7873122
[TBL] [Abstract][Full Text] [Related]
29. The discovery of PD 89211 and related compounds: selective dopamine D4 receptor antagonists.
Pugsley TA; Shih YH; Whetzel SZ; Zoski K; Van Leeuwen D; Akunne H; Mackenzie R; Heffner TG; Wustrow D; Wise LD
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):219-26. PubMed ID: 11817497
[TBL] [Abstract][Full Text] [Related]
30. In vivo binding of [11C]nemonapride to sigma receptors in the cortex and cerebellum.
Ishiwata K; Senda M
Nucl Med Biol; 1999 Aug; 26(6):627-31. PubMed ID: 10587100
[TBL] [Abstract][Full Text] [Related]
31. Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
López-Giménez JF; Vilaró MT; Palacios JM; Mengod G
J Comp Neurol; 2001 Jan; 429(4):571-89. PubMed ID: 11135236
[TBL] [Abstract][Full Text] [Related]
32. Regulation of 5-HT2 receptors in rat cortex. Studies with a putative selective agonist and an antagonist.
Pranzatelli MR
Biochem Pharmacol; 1991 Aug; 42(5):1099-105. PubMed ID: 1872895
[TBL] [Abstract][Full Text] [Related]
33. Characterization of [3H]clozapine binding sites in rat brain.
Kusumi I; Matsubara S; Takahashi Y; Ishikane T; Koyama T
J Neural Transm Gen Sect; 1995; 101(1-3):51-64. PubMed ID: 8695057
[TBL] [Abstract][Full Text] [Related]
34. The effect of streptozotocin-induced diabetes on dopamine2, serotonin1A and serotonin2A receptors in the rat brain.
Sumiyoshi T; Ichikawa J; Meltzer HY
Neuropsychopharmacology; 1997 Mar; 16(3):183-90. PubMed ID: 9138434
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
[TBL] [Abstract][Full Text] [Related]
36. Effects of reserpine treatment on the dopamine receptor binding of [3H/11C]nemonapride in the mouse and rat brain.
Ishiwata K; Onoguchi K; Toyama H; Noguchi J; Senda M
Ann Nucl Med; 1997 Feb; 11(1):21-6. PubMed ID: 9095318
[TBL] [Abstract][Full Text] [Related]
37. Autoradiographic localization of dopamine D2-like receptors in the rat adrenal gland.
Amenta F; Ricci A
Clin Exp Hypertens; 1995 May; 17(4):669-88. PubMed ID: 7795580
[TBL] [Abstract][Full Text] [Related]
38. Enhancement of [m-methoxy 3H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.
Jackson J; Paulose CS
Mol Cell Biochem; 1999 Sep; 199(1-2):81-5. PubMed ID: 10544955
[TBL] [Abstract][Full Text] [Related]
39. Autoradiographic localization of the putative D4 dopamine receptor in rat brain.
Defagot MC; Antonelli MC
Neurochem Res; 1997 Apr; 22(4):401-7. PubMed ID: 9130250
[TBL] [Abstract][Full Text] [Related]
40. Comparison of [3H]nemonapride and [3H]spiperone binding to D2(long) dopamine receptors.
Vile JM; Strange PG
Biochem Soc Trans; 1995 Feb; 23(1):90S. PubMed ID: 7538954
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]